Open Terminal →

Analyses / UNH

UNH UnitedHealth Group Incorporated As of Nov 19, 2026
$349.91

Large-cap managed care after a 10.2% one-day drop. Revenue still growing, earnings shrinking, and the payload does not explain the move.

Setup: Recovery / value, unresolved Confidence: low Horizon: 1-3 months Risk: high Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals UNH's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Revenue growth of 11.35% (5Y: 11.72%) and a P/S of 0.76 leave room for a rebound if the selloff proves sentiment-driven. Insider activity is net buying: 111 buys vs 30 sells, 217,674 shares bought vs 64,377 sold. Trailing P/E of 21.5 is below the forward P/E of 28.3, which could point to a reset. Price sits 24% below the 52-week high of 461.62. Beta of 0.50 is low.

▼ Bear Case

EPS growth is -14.51% (5Y: -3.76%), and forward P/E of 28.3 implies lower expected earnings. Net margin of 2.69% and operating margin of 4.18% leave little cushion. Current ratio 0.89 and quick ratio 0.67 are below 1.0. The session low of 342.46 was far below the prior close of 389.68, so the selling pressure is not yet explained. Payout ratio of 65.66% limits flexibility.

Valuation

MIXED — score 50/100

Low sales multiple and insider buying offset high forward P/E and negative EPS growth. No clear valuation edge in the payload.

Technical Levels

Support · $342.46 (Session low (intraday)) · $255.97 (52-week low)

Resistance · $387.53 (Session high (intraday)) · $389.68 (Prior close) · $461.62 (52-week high)

RSI: Unavailable in payload

Financial Health

Score 45/100. Thin margins and sub-1.0 liquidity ratios are the main concerns. Debt-to-equity is not in payload, so leverage cannot be fully assessed.

Catalysts

Cause of the -10.2% session drop (not identified in payload)Unknownhigh
Next company earnings report (date not in payload)Unknownhigh
Managed-care policy and reimbursement headlines (general sector factor, no payload detail)Ongoingmedium

Risk Flags

The cause of the -10.2% session drop is not in the payload. Headlines are generic and do not explain the move.
Missing from payload: RSI, ROE, ROIC, debt-to-equity, FCF per share, gross margin, and earnings date.
Forward P/E of 28.3 is above trailing P/E of 21.5, implying lower expected earnings. EPS growth is -14.51%.
Current ratio 0.89 and quick ratio 0.67 are below 1.0. Liquidity cushion is thin on these figures.
Price data is a provider snapshot and may be delayed. Verify before using any level.

See UNH's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock UNH free →

Recent News

More Analyses

UNH FAQ

Is UNH a buy right now?

UnitedHealth Group Incorporated's current read is a Recovery / value, unresolved setup with low confidence over a 1-3 months horizon. Valuation: MIXED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is UNH overvalued?

MIXED (valuation score 50/100). Low sales multiple and insider buying offset high forward P/E and negative EPS growth. No clear valuation edge in the payload.

What are the risks of buying UNH?

EPS growth is -14.51% (5Y: -3.76%), and forward P/E of 28.3 implies lower expected earnings. Net margin of 2.69% and operating margin of 4.18% leave little cushion. Current ratio 0.89 and quick ratio 0.67 are below 1.0. The session low of 342.46 was far below the prior close of 389.68, so the selling pressure is not yet explained. Payout ratio of 65.66% limits flexibility.